Clinical Trial Update: Efficacy of a Low-Molecular-Weight Heparin (Bemiparin) in the Treatment of Chronic Foot Ulcers in Diabetic Patients [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating bemiparin for chronic diabetic foot ulcers was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Angiopathy
• Diabetic Foot Ulcer

Drugs mentioned

• Bemiparin (bemiparin)

Snippet

Sponsor: Spanish National Health System | Conditions: Foot Ulcer, Diabetic, Diabetic Angiopathies | Phase 2, Phase 3 | Status: TERMINATED